News | Breast Imaging | August 19, 2022

One of the Cincinnati Region’s top doctors turns to groundbreaking technology to help ensure a better overall experience for breast cancer patients

The Molli device features the smallest localization marker on the market that precisely marks where tumors are located prior to breast cancer surgery, helping the surgeon remove them more efficiently and improving the patient’s overall experience

August 19, 2022 —  The Christ Hospital Health Network, known for providing the best, most compassionate care for its community, is the first in Ohio to adopt Molli Surgical’s wire-free and radiation-free breast cancer localization technology: Molli. The Molli device features the smallest localization marker on the market that precisely marks where tumors are located prior to breast cancer surgery, helping the surgeon remove them more efficiently and improving the patient’s overall experience.  

The Christ Hospital Health Network’s adoption of this technology reflects its commitment to doing everything it takes for patients, such as driving innovations like wire-free localization that improve the patient experience. Going forward, Molli Surgical will be the provider of wire-free, radiation-free technology for breast surgery. 

"Marking the tumor for those needing breast cancer surgery can be a difficult experience for the patient — typically using a wire on the same day of surgery. Molli decouples localization from surgery, providing more flexibility for the patient,” says Jennifer B. Manders, MD. “Plus, the device is easy-to-use, efficient, and extremely precise. We chose Molli after testing other wire-free and radiation-free devices as it had proven to deliver superior results and benefits for the patient, the radiologist, and the surgeon.” 

“Like ourselves, the team at The Christ Hospital Health Network is dedicated to reimagining what healthcare can be and truly understanding patient-first care,” said Fazila Seker, Ph.D., President, and CEO of Molli Surgical Inc. “We are committed to helping them create more efficiencies in their radiology and surgery departments and deliver exceptional outcomes and experiences for their patients.” 

Molli Surgical’s FDA-cleared Molli allows surgeons to pinpoint cancerous tissue for faster, more accurate, and less painful tumor removal, offering an improved experience and better cosmetic outcomes for breast cancer patients, as well as patients living with different types of cancers. The wire-free technology includes the Molli Marker, about the size of a sesame seed, that can be detected using the Molli Wand and the Molli Tablet.  

For more information: mollisurgical.com 


Related Content

News | ASTRO

October 6, 2022 ‑— Ahead of the 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO), set for ...

Time October 06, 2022
arrow
News | Women's Health

October 5, 2022 — Hologic, Inc. Chairman, President and CEO Steve MacMillan rang the Nasdaq opening bell on Monday, Oct ...

Time October 05, 2022
arrow
News | Women's Health

October 4, 2022 — For Black women, breast cancer is the most commonly diagnosed cancer and as of 2019 has surpassed lung ...

Time October 04, 2022
arrow
Feature | Radiology Business

Here is a recap of what ITN viewers found most interesting during the month of September: 1. Lasting Lung Damage Seen in ...

Time October 03, 2022
arrow
News | Breast Imaging

October 3, 2022 — “Breast cancer doesn’t wait—everything else can.” That’s the message and sense of urgency behind PINK ...

Time October 03, 2022
arrow
News | ASTRO

The 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO) will take place October 23-26, at the ...

Time September 29, 2022
arrow
Feature | Radiology Imaging

View the September/October digital edition of Imaging Technology News (ITN), including links to videos, comparison ...

Time September 29, 2022
arrow
News | Radiation Therapy

September 29, 2022 — Radformation Inc and Videra Surgical are pleased to announce a collaboration integrating Videra ...

Time September 29, 2022
arrow
News | PET Imaging

September 28, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 28, 2022
arrow
News | PET-CT

September 28, 2022 — Xoran Technologies is engaged in a ground-breaking research project to develop a PET/CT scanner for ...

Time September 28, 2022
arrow
Subscribe Now